MN SF4486

Authorizes licensed pharmacists to prescribe, administer, and dispense Schedule III through V controlled substances for treating opioid use disorder, including medications like buprenorphine

Requires pharmacists to complete federally-approved training for substance use disorder treatment and obtain appropriate DEA registration before prescribing these medications

Mandates pharmacists document patient assessments, treatment plans, responses, and monitoring activities in health records, and provide counseling on proper drug use before dispensing

Prohibits pharmacists from delegating prescribing authority, though pharmacy interns may prepare prescriptions under pharmacist review and supervision

Adds new disciplinary grounds for pharmacists and pharmacy interns who fail to conform with accepted standards of care, expanding Board of Pharmacy enforcement authority